An interventional study of green tea powder in Cognitive Impairment, sponsored by University of Shizuoka. Completed at 1 site in Japan. Open to participants aged 50 Years to 95 Years. Per ClinicalTrials.gov, last updated 2013-07-16.
Sponsored by University of Shizuoka · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Cognitive Dysfunction with a site in Japan — 4 open to participants now, 9 under way, 6 of them phase 3. Cognitive Dysfunction · Japan.
Among the 28 studies in Cognitive Dysfunction with a site in Japan, this one is the 26th largest by planned enrollment of the 26 interventional ones that give a count, is one of 3 that started in 2012, is one of 2 with no phase, and was the 6th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →4 of the 28 studies in Cognitive Dysfunction with a site in Japan are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Japan, United States, Korea, Republic of and 1 more country
Ages 55–85
Bristol-Myers Squibb · Sites in Japan, United States, Argentina and 14 more countries
Ages 60–85
Hoffmann-La Roche · Sites in Japan, United States, Argentina and 12 more countries
Ages 50–90
Eli Lilly and Company · Sites in Japan, United States, United Kingdom
Ages 50–85
A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 50 Years to 95 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 10 · Phase 3 11 · Phase 4 1
First in 2003; this study’s year is marked. 3 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 378 across the 26 interventional studies, 226 across the 2 observational. Of the 17 that completed or were terminated, 10 (59%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 28 have an industry lead sponsor. The 10 most frequent:
University of Shizuoka is the lead sponsor of 11 studies on the registry; 1 is open to participants now.
University of Shizuoka has 1 study filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
1 of the studies in Cognitive Dysfunction with a site in Japan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Cognitive Dysfunction with a site in Japan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Green tea contains catechins and theanine as major ingredients and has been reported to have various beneficial influences on human health. It is reported that the drinking green tea is inversely associated with serum homocysteine level in elderly. However the effect of green tea consumption on cognitive dysfunction is not clinically clarified. The purpose of this study is to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.
Elderly people with impaired cognitive function go on increasing year by year with the coming aged society. Among them, the Alzheimer disease is a major cause of the illness, which is progressively worse, has no fundamental curable therapy, and induces the burdens of caregivers as well as the health insurance and national budget. Recently, homocysteine metabolism is reported to be related to atherosclerosis in aging, and draw attention as the etiology of cognitive dysfunction in elderly.
Green tea contains catechins and theanine as main ingredients. These components are reported to have anti-atherogenic action and effect on improving cognitive dysfunction. However, clinical evidence for homocysteine metabolism and cognitive dysfunction has not been clarified. Therefore, in this study, the investigators attempted to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Natural green tea powder
Dietary Supplement: green tea powder
Consuming 2 g/day of green tea powder in three times divided for 3 months
Changes in the serum homocysteine levels
Changes in the serum homocysteine levels before and after the intervention
Time frame: between baseline and 3 months after
Changes in serum lipid levels
Changes in serum lipid levels before and after the intervention
Time frame: between baseline and 3 months after
Changes in serum folic acid levels
Changes in serum folic acid levels before and after the intervention
Time frame: between baseline and 3 months after
Changes in mini mental state examination (MMSE) scores
Changes in mini mental state examination (MMSE) scores before and after the intervention
Time frame: between baseline and 3 months after
The record gives a start of May 2012, a primary completion of Jul 2013 and a completion of Jul 2013. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tea
University of Shizuoka